Changes in cerebral endothelial barrier antigen, without alteration of permeability for intravenously injected leptin in diet-induced obesity in rats

Experimental and Toxicologic Pathology

Volumn 55, Issue 1, 2003, Pages 45-49

  Nave, Heike ^a   Kuhlmann, Susanne ^a   Brabant, Georg ^a   Pabst, Reinhard ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Blood brain barrier; Diet induced obesity; Endothelial barrier antigen; Leptin; Rat

Indexed keywords

BRAIN ANTIGEN; LEPTIN; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CELL; BRAIN CIRCULATION; BRAIN CORTEX; CELL MEMBRANE PERMEABILITY; CEREBROSPINAL FLUID ANALYSIS; CISTERNA MAGNA; CONTROLLED STUDY; DIET; ENDOTHELIUM CELL; HIPPOCAMPUS; HYPOTHALAMUS; IMMUNOHISTOLOGY; MALE; MICROVASCULATURE; NEUROPATHOLOGY; NONHUMAN; OBESITY; PATHOGENESIS; RADIOACTIVITY; RAT; RAT STRAIN;

ANIMALIA;

EID: 0043027033     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1078/0940-2993-00300     Document Type: Article

References (25)

1. AHIMA RS, FLIER JS: Leptin. Annu Rev Physiol 2000; 62: 413-437.
2. ALLISON DB, FONTAINE KR, MANSON JE, et al.: Annual deaths attributable to obesity in the United States. JAMA 1999; 282: 1530-1538.
3. BANKS WA, KASTIN AJ, HUANG W, et al.: Leptin enters the brain by a saturable system independent of insulin. Peptides 1996; 17: 305-311.
4. BANKS WA, DIPALMA CR, FARRELL CL: Impaired transport of leptin across the blood-brain barrier in obesity. Peptides 1999; 20: 1341-1345.
5. BJORBAEK C, ELMQUIST JK, MICHL P, et al.: Expression of leptin receptor isoforms in rat brain microvessels. Endocrinology 1998; 139: 3485-3491.
6. BRABANT G, NAVE H, MAYR B, et al.: Secretion of free and protein-bound leptin from subcutaneous adipose tissue of lean and obese women. J Clin Endocrinol Metab 2002; 87: 3966-3970.
7. BRAY G, BOUCHARD C: Genetics of human obesity: research directions. Faseb J 1997; 11: 937-945.
8. BURGUERA B, COUCE ME, LONG J, et al.: The long form of the leptin receptor (OB-Rb) is widely expressed in the human brain. Neuroendocrinology 2000; 61: 187-195.
9. CARO JF, KOLACZYNSKI JW, NYCE MR, et al.: Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 1996; 348: 159-161.
10. FREDERICH RC, HAMANN A, ANDERSON S, et al.: Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1995; 1: 1311-1314.
11. FRIEDMANN JM, HALAAS JL: Leptin and the regulation of body weight in mammals. Nature 1998; 395: 763-770.
12. GHABRIEL MN, ZHU C, HERMANIS G, et al.: Immunological targeting of the endothelial barrier antigen (EBA) in vivo leads to opening of the blood-brain barrier. Brain Res 2000; 878: 127-135.
13. GOLDEN PL, MACCAGNAN TJ, PARDRIDGE WM: Human blood-brain barrier leptin receptor. Binding and endocytosis in isolated human brain microvessels. J Clin Invest 1997; 99: 14-18.
14. HAKANSSON ML, BROWN H, GHILARDI N, et al.: Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus. J Neurosci 1998; 18: 559-572.
15. LEE J, MORRIS MJ: Modulation of neuropeptide Y overflow by leptin in the rat hypothalamus, cerebral cortex and medulla. Neuroreport 1998; 9: 1575-1580.
16. MOORADIAN AD, GRABAU G, UKO-ENIN A: In situ quantitative estimates of the age-related and diabetes-related changes in cerebral endothelial barrier antigen. Brain Res 1993; 609: 41-44.
17. NAVE H, VON HORSTEN S, HELFRITZ F, et al.: Intravenous cannulation of the freely behaving rat: frequent blood sampling and volume-dependent effect on blood leukocyte counts. J Exp Anim Sci 1998; 39: 67-77.
18. PERDIKI M, FAROOQUE M, HOLTZ A, et al.: Expression of endothelial barrier antigen immunoreactivity in blood vessels following compression trauma to rat spinal cord. Temporal evolution and relation to the degree of the impact. Acta Neuropathol 1998; 96: 8-12.
19. SCHWARTZ MW, SEELEY RJ, CAMPFIELD LA, et al.: Identification of targets of leptin action in rat hypothalamus. J Clin Invest 1996a; 98: 1101-1106.
20. SCHWARTZ MW, PESKIND E, RASKIND M, et al.: Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med 1996b; 2: 589-593.
21. STERNBERGER NH, STERNBERGER LA: Blood-brain barrier protein recognized by monoclonal antibody. P Natl Acad Sci USA 1987; 84: 8169-8173.
22. STERNBERGER NH, STERNBERGER LA, KIES MW, et al.: Cell surface endothelial proteins altered in experimental allergic encephalomyelitis. J Neuroimmunol 1989; 21: 241-248.
23. WIDDOWSON PS, UPTON R, BUCKINGHAM R, et al.: Inhibition of food response to intracerebroventricular injection of leptin is attenuated in rats with diet-induced obesity. Diabetes 1997; 46: 1782-1785.
24. ZHANG Y, PROENCA R, MAFFEI M, et al.: Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432.
25. ZLOKOVIC BV, JOVANOVIC S, MIAO W, et al.: Differential regulation of leptin transport by the choroid plexus and blood-brain barrier and high affinity transport systems for entry into the hypothalamus and across the blood-cerebrospinal fluid barrier. Endocrinology 2000; 141: 1434-1441.